All investigators in the field of clinical pharmacy and clinical pharmacology, ACCP members and nonmembers alike, are invited to submit abstracts to be considered for presentation at:

1. NEW ACCP Updates in Therapeutics^® 2018 (UT) in February,
2. 2018 ACCP Virtual Poster Symposium (VPS) in May, and
3. 2018 ACCP Global Conference on Clinical Pharmacy (GCCP) in October.

Please note:

• ACCP’s February meeting will continue to deliver best-in-class specialty certification preparatory review and recertification courses and ACCP Academy programming, now with two scientific poster presentation sessions, and the Patient-Centered, Team-Based Care Forum. Submit an abstract for presentation and plan to join us February 16–18, 2018, at the Hyatt Regency Jacksonville Riverfront Hotel in Jacksonville, Florida.
• Positioned between the two live 2018 ACCP meetings, the VPS will provide an additional venue for investigators to disseminate findings to both a national and an international audience online. The 2018 ACCP VPS will be held May 23 and 24, 2018.
• The premier gathering for clinical pharmacists from around the world to exchange new knowledge and experiences in research, practice, education, and training, the ACCP Global Conference on Clinical Pharmacy at the Washington State Conference Center in Seattle, Washington, will be held October 20–23, 2018.

All abstracts accepted for presentation, except for “Encore” and “Research-in-Progress” presentations, will be published online in Pharmacotherapy. Only the abstract title, authors, and original citation will be published for “Encore” presentations. All accepted abstracts will be provided full-text in the ACCP meeting app or the VPS platform. Posters from all categories will be distributed across the poster display sessions/days.

To review the complete submission instructions, guidelines, and review criteria, or to submit an abstract for one or more of these three venues, visit the ACCP website.

ABSTRACT CATEGORIES (venue(s) at which this category is available):

Original Research (UT, VPS, GCCP): Abstracts must summarize quantitative or qualitative findings from completed research. Basic, clinical, translational, dissemination/implementation, and educational research are examples of acceptable research. Topics should be relevant to a clinical pharmacy audience and may include research in drug metabolism, education/pedagogy, health services, medication safety, patient/population outcomes, pharmacokinetics, pharmacodynamics, pharmacoeconomics, pharmacoepidemiology, pharmacogenomics, pharmacology, or pharmacotherapy. Abstracts reporting in vitro or animal research are invited. Encore submissions are also welcome.

Systematic Reviews/Meta-Analyses (VPS, GCCP): Abstracts must describe a systematic review adhering to the guidelines and definitions established by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and include the 12 items published in the PRISMA for Abstracts checklist.

Case Reports (VPS, GCCP): Abstracts of case reports must update and expand therapeutic insights and possibilities, or generate research hypotheses. Although narrative in nature, these abstracts must also stress the “evidence” for the authors’ conclusions by describing the process followed to understand the findings and possible mechanisms involved in the patient’s case, how the patient was evaluated and treated, and a specific description of the outcome.

Research-in-Progress (UT): Submission guidelines are those of an Original Research abstract except that the research effort is ongoing at the time of abstract submission.

Resident and Fellow Research-in-Progress (VPS, GCCP): Submission guidelines are those of an Original Research abstract except that the research effort is ongoing at the time of abstract submission.

Student Research-in-Progress (VPS, GCCP): Submission guidelines are those of an Original Research abstract except that the research effort is ongoing at the time of abstract submission.

Clinical Pharmacy Forum (UT, VPS, GCCP): Abstracts must describe the delivery, justification, documentation, adaptability, and impact/significance of innovative clinical pharmacy services. Abstracts that address comprehensive medication management implementation components of the ACCP Standards of Practice for Clinical Pharmacists and/or describe efforts to develop, advance, or position clinical pharmacists to optimize patient care are encouraged. Abstracts may be descriptive and need not contain an evaluative component. Encore submissions are welcome.

Advances in International Clinical Pharmacy Practice, Education, or Training (VPS, GCCP): Abstracts must describe the delivery of justification or documentation for, and significance of, clinical pharmacy practice, education, or training outside the United States. Abstracts may be descriptive and need not contain an evaluative component.

Encore Presentations (UT, VPS, GCCP): Submission and evaluation criteria are those of the Original Research or Clinical Pharmacy Forum category, except that the same abstract was presented elsewhere or published in abstract form only before this meeting. Abstracts submitted for Encore Presentations must not be modified from the previously presented/published version. This includes the title, authors, and abstract body. The presenting author may differ, but he or she must be an author on the original abstract.

Important Dates:

NEW ACCP Updates in Therapeutics^® 2018 in February

Call for abstracts is open to all meeting registrants (i.e., prep course; Academy; and Patient-Centered, Team-Based Care Forum attendees).

• Regular Decision (accept/decline notification by January 12, 2018)
• November 27, 2017: Regular decision submission deadline for Original Research and Clinical Pharmacy Forum abstracts.
• January 3, 2018: Regular decision submission deadline for Research-in-Progress abstracts (includes students, trainees, and non-student/non-trainee investigators).

ACCP Virtual Poster Symposium in May

• Regular Decision (accept/decline notification by March 30, 2018)
• January 26, 2018: Regular decision submission deadline for all categories of abstracts except Research-in-Progress (Students and Residents and Fellows).
• March 15, 2018: Regular decision abstract submission deadline for Research-in-Progress abstracts (Students and Residents and Fellows).

ACCP Global Conference on Clinical Pharmacy in October

• Early Decision (accept/decline notification by April 16, 2018)
• February 15, 2018: Early decision submission deadline for all abstract categories (Original Research; Systematic Reviews; Case Reports; Clinical Pharmacy Forum; Advances in International Clinical Pharmacy Practice, Education, or Training Abstracts; and Research-in-Progress [Students and Residents and Fellows]).
• Regular Decision (accept/decline notification by August 15, 2018)
• June 15, 2018: Regular decision submission deadline for Original Research, Systematic Reviews, Case Reports, Clinical Pharmacy Forum, and Advances in International Clinical Pharmacy Practice, Education, or Training abstracts.
• July 15, 2018: Regular decision submission deadline for Research-in-Progress abstracts (Students and Residents and Fellows).

To review the complete submission instructions, guidelines, and review criteria, or to submit an abstract for one or more of these three opportunities, visit the ACCP website.